nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—PGR—Betamethasone—ankylosing spondylitis	0.156	0.343	CbGbCtD
Levonorgestrel—PGR—Dexamethasone—ankylosing spondylitis	0.0905	0.2	CbGbCtD
Levonorgestrel—CYP19A1—Betamethasone—ankylosing spondylitis	0.0875	0.193	CbGbCtD
Levonorgestrel—Danazol—Prednisone—ankylosing spondylitis	0.0629	0.133	CrCrCtD
Levonorgestrel—CYP19A1—Dexamethasone—ankylosing spondylitis	0.0509	0.112	CbGbCtD
Levonorgestrel—Progesterone—Prednisolone—ankylosing spondylitis	0.045	0.0953	CrCrCtD
Levonorgestrel—Methyltestosterone—Prednisone—ankylosing spondylitis	0.0449	0.0952	CrCrCtD
Levonorgestrel—Methyltestosterone—Prednisolone—ankylosing spondylitis	0.0438	0.0929	CrCrCtD
Levonorgestrel—Hydrocortisone—Methylprednisolone—ankylosing spondylitis	0.0412	0.0873	CrCrCtD
Levonorgestrel—Hydrocortisone—Dexamethasone—ankylosing spondylitis	0.0405	0.0859	CrCrCtD
Levonorgestrel—Hydrocortisone—Betamethasone—ankylosing spondylitis	0.0405	0.0859	CrCrCtD
Levonorgestrel—Hydrocortisone—Triamcinolone—ankylosing spondylitis	0.0396	0.0839	CrCrCtD
Levonorgestrel—Testosterone—Prednisolone—ankylosing spondylitis	0.039	0.0828	CrCrCtD
Levonorgestrel—Hydrocortisone—Prednisone—ankylosing spondylitis	0.0376	0.0797	CrCrCtD
Levonorgestrel—Hydrocortisone—Prednisolone—ankylosing spondylitis	0.0367	0.0777	CrCrCtD
Levonorgestrel—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.017	0.0376	CbGbCtD
Levonorgestrel—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0129	0.0285	CbGbCtD
Levonorgestrel—CYP3A4—Betamethasone—ankylosing spondylitis	0.0111	0.0245	CbGbCtD
Levonorgestrel—CYP3A4—Prednisolone—ankylosing spondylitis	0.0109	0.0241	CbGbCtD
Levonorgestrel—CYP3A4—Prednisone—ankylosing spondylitis	0.0103	0.0228	CbGbCtD
Levonorgestrel—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00645	0.0142	CbGbCtD
Levonorgestrel—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000143	0.0019	CcSEcCtD
Levonorgestrel—Alopecia—Dexamethasone—ankylosing spondylitis	0.000141	0.00188	CcSEcCtD
Levonorgestrel—Alopecia—Betamethasone—ankylosing spondylitis	0.000141	0.00188	CcSEcCtD
Levonorgestrel—Discomfort—Prednisolone—ankylosing spondylitis	0.00014	0.00187	CcSEcCtD
Levonorgestrel—Angioedema—Triamcinolone—ankylosing spondylitis	0.00014	0.00187	CcSEcCtD
Levonorgestrel—Haemoglobin—Prednisone—ankylosing spondylitis	0.00014	0.00186	CcSEcCtD
Levonorgestrel—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00014	0.00186	CcSEcCtD
Levonorgestrel—Haemorrhage—Prednisone—ankylosing spondylitis	0.000139	0.00186	CcSEcCtD
Levonorgestrel—Erythema—Dexamethasone—ankylosing spondylitis	0.000139	0.00185	CcSEcCtD
Levonorgestrel—Erythema—Betamethasone—ankylosing spondylitis	0.000139	0.00185	CcSEcCtD
Levonorgestrel—Vertigo—Triamcinolone—ankylosing spondylitis	0.000138	0.00184	CcSEcCtD
Levonorgestrel—Syncope—Triamcinolone—ankylosing spondylitis	0.000138	0.00183	CcSEcCtD
Levonorgestrel—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000138	0.00183	CcSEcCtD
Levonorgestrel—Syncope—Methylprednisolone—ankylosing spondylitis	0.000137	0.00183	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000137	0.00182	CcSEcCtD
Levonorgestrel—Oedema—Prednisolone—ankylosing spondylitis	0.000136	0.00181	CcSEcCtD
Levonorgestrel—Dysuria—Methotrexate—ankylosing spondylitis	0.000136	0.00181	CcSEcCtD
Levonorgestrel—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000135	0.0018	CcSEcCtD
Levonorgestrel—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000135	0.0018	CcSEcCtD
Levonorgestrel—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000135	0.00179	CcSEcCtD
Levonorgestrel—Shock—Prednisolone—ankylosing spondylitis	0.000134	0.00178	CcSEcCtD
Levonorgestrel—Cough—Triamcinolone—ankylosing spondylitis	0.000134	0.00178	CcSEcCtD
Levonorgestrel—Hypertension—Triamcinolone—ankylosing spondylitis	0.000132	0.00176	CcSEcCtD
Levonorgestrel—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000132	0.00176	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000132	0.00175	CcSEcCtD
Levonorgestrel—Myalgia—Triamcinolone—ankylosing spondylitis	0.000131	0.00174	CcSEcCtD
Levonorgestrel—Pneumonia—Methotrexate—ankylosing spondylitis	0.00013	0.00174	CcSEcCtD
Levonorgestrel—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00013	0.00174	CcSEcCtD
Levonorgestrel—Eye disorder—Prednisone—ankylosing spondylitis	0.00013	0.00173	CcSEcCtD
Levonorgestrel—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00013	0.00173	CcSEcCtD
Levonorgestrel—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00013	0.00173	CcSEcCtD
Levonorgestrel—Infestation—Methotrexate—ankylosing spondylitis	0.00013	0.00173	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000129	0.00172	CcSEcCtD
Levonorgestrel—Depression—Methotrexate—ankylosing spondylitis	0.000129	0.00172	CcSEcCtD
Levonorgestrel—Discomfort—Triamcinolone—ankylosing spondylitis	0.000129	0.00172	CcSEcCtD
Levonorgestrel—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000129	0.00172	CcSEcCtD
Levonorgestrel—Angioedema—Dexamethasone—ankylosing spondylitis	0.000127	0.00169	CcSEcCtD
Levonorgestrel—Angioedema—Betamethasone—ankylosing spondylitis	0.000127	0.00169	CcSEcCtD
Levonorgestrel—Immune system disorder—Prednisone—ankylosing spondylitis	0.000126	0.00168	CcSEcCtD
Levonorgestrel—Oedema—Triamcinolone—ankylosing spondylitis	0.000125	0.00167	CcSEcCtD
Levonorgestrel—Vertigo—Betamethasone—ankylosing spondylitis	0.000125	0.00167	CcSEcCtD
Levonorgestrel—Vertigo—Dexamethasone—ankylosing spondylitis	0.000125	0.00167	CcSEcCtD
Levonorgestrel—Syncope—Dexamethasone—ankylosing spondylitis	0.000125	0.00166	CcSEcCtD
Levonorgestrel—Syncope—Betamethasone—ankylosing spondylitis	0.000125	0.00166	CcSEcCtD
Levonorgestrel—Arrhythmia—Prednisone—ankylosing spondylitis	0.000124	0.00166	CcSEcCtD
Levonorgestrel—Infection—Triamcinolone—ankylosing spondylitis	0.000124	0.00166	CcSEcCtD
Levonorgestrel—Infection—Methylprednisolone—ankylosing spondylitis	0.000124	0.00165	CcSEcCtD
Levonorgestrel—Shock—Triamcinolone—ankylosing spondylitis	0.000123	0.00164	CcSEcCtD
Levonorgestrel—Insomnia—Prednisolone—ankylosing spondylitis	0.000123	0.00164	CcSEcCtD
Levonorgestrel—Alopecia—Prednisone—ankylosing spondylitis	0.000123	0.00164	CcSEcCtD
Levonorgestrel—Shock—Methylprednisolone—ankylosing spondylitis	0.000123	0.00164	CcSEcCtD
Levonorgestrel—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000123	0.00163	CcSEcCtD
Levonorgestrel—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000122	0.00163	CcSEcCtD
Levonorgestrel—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000122	0.00163	CcSEcCtD
Levonorgestrel—Mental disorder—Prednisone—ankylosing spondylitis	0.000122	0.00163	CcSEcCtD
Levonorgestrel—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000121	0.00162	CcSEcCtD
Levonorgestrel—Erythema—Prednisone—ankylosing spondylitis	0.000121	0.00161	CcSEcCtD
Levonorgestrel—Malnutrition—Prednisone—ankylosing spondylitis	0.000121	0.00161	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000121	0.00161	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000121	0.00161	CcSEcCtD
Levonorgestrel—Hypertension—Dexamethasone—ankylosing spondylitis	0.00012	0.0016	CcSEcCtD
Levonorgestrel—Hypertension—Betamethasone—ankylosing spondylitis	0.00012	0.0016	CcSEcCtD
Levonorgestrel—Myalgia—Dexamethasone—ankylosing spondylitis	0.000119	0.00158	CcSEcCtD
Levonorgestrel—Myalgia—Betamethasone—ankylosing spondylitis	0.000119	0.00158	CcSEcCtD
Levonorgestrel—Anxiety—Dexamethasone—ankylosing spondylitis	0.000118	0.00157	CcSEcCtD
Levonorgestrel—Anxiety—Betamethasone—ankylosing spondylitis	0.000118	0.00157	CcSEcCtD
Levonorgestrel—Discomfort—Dexamethasone—ankylosing spondylitis	0.000117	0.00156	CcSEcCtD
Levonorgestrel—Discomfort—Betamethasone—ankylosing spondylitis	0.000117	0.00156	CcSEcCtD
Levonorgestrel—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000117	0.00156	CcSEcCtD
Levonorgestrel—Pain—Prednisolone—ankylosing spondylitis	0.000116	0.00155	CcSEcCtD
Levonorgestrel—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000116	0.00155	CcSEcCtD
Levonorgestrel—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000116	0.00154	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000115	0.00153	CcSEcCtD
Levonorgestrel—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000114	0.00152	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000114	0.00152	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000114	0.00152	CcSEcCtD
Levonorgestrel—Oedema—Betamethasone—ankylosing spondylitis	0.000114	0.00151	CcSEcCtD
Levonorgestrel—Oedema—Dexamethasone—ankylosing spondylitis	0.000114	0.00151	CcSEcCtD
Levonorgestrel—Insomnia—Triamcinolone—ankylosing spondylitis	0.000113	0.00151	CcSEcCtD
Levonorgestrel—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000113	0.00151	CcSEcCtD
Levonorgestrel—Infection—Dexamethasone—ankylosing spondylitis	0.000113	0.0015	CcSEcCtD
Levonorgestrel—Infection—Betamethasone—ankylosing spondylitis	0.000113	0.0015	CcSEcCtD
Levonorgestrel—Visual impairment—Methotrexate—ankylosing spondylitis	0.000112	0.00149	CcSEcCtD
Levonorgestrel—Anaemia—Prednisone—ankylosing spondylitis	0.000112	0.00149	CcSEcCtD
Levonorgestrel—Shock—Dexamethasone—ankylosing spondylitis	0.000112	0.00149	CcSEcCtD
Levonorgestrel—Shock—Betamethasone—ankylosing spondylitis	0.000112	0.00149	CcSEcCtD
Levonorgestrel—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000112	0.00149	CcSEcCtD
Levonorgestrel—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000111	0.00148	CcSEcCtD
Levonorgestrel—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000111	0.00148	CcSEcCtD
Levonorgestrel—Angioedema—Prednisone—ankylosing spondylitis	0.000111	0.00148	CcSEcCtD
Levonorgestrel—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00011	0.00147	CcSEcCtD
Levonorgestrel—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00011	0.00147	CcSEcCtD
Levonorgestrel—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00011	0.00146	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00011	0.00146	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00011	0.00146	CcSEcCtD
Levonorgestrel—Vertigo—Prednisone—ankylosing spondylitis	0.000109	0.00145	CcSEcCtD
Levonorgestrel—Eye disorder—Methotrexate—ankylosing spondylitis	0.000109	0.00145	CcSEcCtD
Levonorgestrel—Syncope—Prednisone—ankylosing spondylitis	0.000109	0.00145	CcSEcCtD
Levonorgestrel—Anorexia—Dexamethasone—ankylosing spondylitis	0.000108	0.00144	CcSEcCtD
Levonorgestrel—Anorexia—Betamethasone—ankylosing spondylitis	0.000108	0.00144	CcSEcCtD
Levonorgestrel—Urticaria—Prednisolone—ankylosing spondylitis	0.000108	0.00144	CcSEcCtD
Levonorgestrel—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000108	0.00144	CcSEcCtD
Levonorgestrel—Fatigue—Triamcinolone—ankylosing spondylitis	0.000108	0.00144	CcSEcCtD
Levonorgestrel—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000108	0.00143	CcSEcCtD
Levonorgestrel—Pain—Triamcinolone—ankylosing spondylitis	0.000107	0.00143	CcSEcCtD
Levonorgestrel—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000107	0.00142	CcSEcCtD
Levonorgestrel—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000105	0.0014	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000105	0.0014	CcSEcCtD
Levonorgestrel—Hypertension—Prednisone—ankylosing spondylitis	0.000105	0.00139	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000104	0.00138	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000104	0.00138	CcSEcCtD
Levonorgestrel—Myalgia—Prednisone—ankylosing spondylitis	0.000103	0.00137	CcSEcCtD
Levonorgestrel—Anxiety—Prednisone—ankylosing spondylitis	0.000103	0.00137	CcSEcCtD
Levonorgestrel—Alopecia—Methotrexate—ankylosing spondylitis	0.000103	0.00137	CcSEcCtD
Levonorgestrel—Insomnia—Dexamethasone—ankylosing spondylitis	0.000103	0.00137	CcSEcCtD
Levonorgestrel—Insomnia—Betamethasone—ankylosing spondylitis	0.000103	0.00137	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000103	0.00137	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000102	0.00136	CcSEcCtD
Levonorgestrel—Discomfort—Prednisone—ankylosing spondylitis	0.000102	0.00136	CcSEcCtD
Levonorgestrel—Mental disorder—Methotrexate—ankylosing spondylitis	0.000102	0.00136	CcSEcCtD
Levonorgestrel—Erythema—Methotrexate—ankylosing spondylitis	0.000101	0.00135	CcSEcCtD
Levonorgestrel—Malnutrition—Methotrexate—ankylosing spondylitis	0.000101	0.00135	CcSEcCtD
Levonorgestrel—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.0001	0.00134	CcSEcCtD
Levonorgestrel—Dyspepsia—Betamethasone—ankylosing spondylitis	0.0001	0.00133	CcSEcCtD
Levonorgestrel—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.0001	0.00133	CcSEcCtD
Levonorgestrel—Urticaria—Triamcinolone—ankylosing spondylitis	9.95e-05	0.00132	CcSEcCtD
Levonorgestrel—Urticaria—Methylprednisolone—ankylosing spondylitis	9.93e-05	0.00132	CcSEcCtD
Levonorgestrel—Body temperature increased—Triamcinolone—ankylosing spondylitis	9.9e-05	0.00132	CcSEcCtD
Levonorgestrel—Oedema—Prednisone—ankylosing spondylitis	9.89e-05	0.00132	CcSEcCtD
Levonorgestrel—Abdominal pain—Methylprednisolone—ankylosing spondylitis	9.88e-05	0.00132	CcSEcCtD
Levonorgestrel—Decreased appetite—Dexamethasone—ankylosing spondylitis	9.88e-05	0.00132	CcSEcCtD
Levonorgestrel—Decreased appetite—Betamethasone—ankylosing spondylitis	9.88e-05	0.00132	CcSEcCtD
Levonorgestrel—Infection—Prednisone—ankylosing spondylitis	9.83e-05	0.00131	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	9.81e-05	0.00131	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	9.81e-05	0.00131	CcSEcCtD
Levonorgestrel—Back pain—Methotrexate—ankylosing spondylitis	9.8e-05	0.00131	CcSEcCtD
Levonorgestrel—Fatigue—Dexamethasone—ankylosing spondylitis	9.8e-05	0.0013	CcSEcCtD
Levonorgestrel—Fatigue—Betamethasone—ankylosing spondylitis	9.8e-05	0.0013	CcSEcCtD
Levonorgestrel—Shock—Prednisone—ankylosing spondylitis	9.73e-05	0.0013	CcSEcCtD
Levonorgestrel—Pain—Betamethasone—ankylosing spondylitis	9.72e-05	0.00129	CcSEcCtD
Levonorgestrel—Pain—Dexamethasone—ankylosing spondylitis	9.72e-05	0.00129	CcSEcCtD
Levonorgestrel—Nervous system disorder—Prednisone—ankylosing spondylitis	9.7e-05	0.00129	CcSEcCtD
Levonorgestrel—Skin disorder—Prednisone—ankylosing spondylitis	9.61e-05	0.00128	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Prednisone—ankylosing spondylitis	9.56e-05	0.00127	CcSEcCtD
Levonorgestrel—Anorexia—Prednisone—ankylosing spondylitis	9.43e-05	0.00126	CcSEcCtD
Levonorgestrel—Anaemia—Methotrexate—ankylosing spondylitis	9.36e-05	0.00125	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	9.29e-05	0.00124	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	9.29e-05	0.00124	CcSEcCtD
Levonorgestrel—Hypersensitivity—Triamcinolone—ankylosing spondylitis	9.23e-05	0.00123	CcSEcCtD
Levonorgestrel—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	9.2e-05	0.00123	CcSEcCtD
Levonorgestrel—Vertigo—Methotrexate—ankylosing spondylitis	9.1e-05	0.00121	CcSEcCtD
Levonorgestrel—Urticaria—Dexamethasone—ankylosing spondylitis	9.03e-05	0.0012	CcSEcCtD
Levonorgestrel—Urticaria—Betamethasone—ankylosing spondylitis	9.03e-05	0.0012	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	9.01e-05	0.0012	CcSEcCtD
Levonorgestrel—Dizziness—Prednisolone—ankylosing spondylitis	9e-05	0.0012	CcSEcCtD
Levonorgestrel—Asthenia—Triamcinolone—ankylosing spondylitis	8.98e-05	0.0012	CcSEcCtD
Levonorgestrel—Abdominal pain—Dexamethasone—ankylosing spondylitis	8.98e-05	0.0012	CcSEcCtD
Levonorgestrel—Abdominal pain—Betamethasone—ankylosing spondylitis	8.98e-05	0.0012	CcSEcCtD
Levonorgestrel—Body temperature increased—Betamethasone—ankylosing spondylitis	8.98e-05	0.0012	CcSEcCtD
Levonorgestrel—Body temperature increased—Dexamethasone—ankylosing spondylitis	8.98e-05	0.0012	CcSEcCtD
Levonorgestrel—Asthenia—Methylprednisolone—ankylosing spondylitis	8.96e-05	0.00119	CcSEcCtD
Levonorgestrel—Insomnia—Prednisone—ankylosing spondylitis	8.95e-05	0.00119	CcSEcCtD
Levonorgestrel—Pruritus—Triamcinolone—ankylosing spondylitis	8.86e-05	0.00118	CcSEcCtD
Levonorgestrel—Cough—Methotrexate—ankylosing spondylitis	8.84e-05	0.00118	CcSEcCtD
Levonorgestrel—Pruritus—Methylprednisolone—ankylosing spondylitis	8.84e-05	0.00118	CcSEcCtD
Levonorgestrel—Dyspepsia—Prednisone—ankylosing spondylitis	8.71e-05	0.00116	CcSEcCtD
Levonorgestrel—Chest pain—Methotrexate—ankylosing spondylitis	8.63e-05	0.00115	CcSEcCtD
Levonorgestrel—Myalgia—Methotrexate—ankylosing spondylitis	8.63e-05	0.00115	CcSEcCtD
Levonorgestrel—Decreased appetite—Prednisone—ankylosing spondylitis	8.6e-05	0.00115	CcSEcCtD
Levonorgestrel—Rash—Prednisolone—ankylosing spondylitis	8.59e-05	0.00114	CcSEcCtD
Levonorgestrel—Dermatitis—Prednisolone—ankylosing spondylitis	8.58e-05	0.00114	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	8.57e-05	0.00114	CcSEcCtD
Levonorgestrel—Diarrhoea—Methylprednisolone—ankylosing spondylitis	8.55e-05	0.00114	CcSEcCtD
Levonorgestrel—Fatigue—Prednisone—ankylosing spondylitis	8.53e-05	0.00114	CcSEcCtD
Levonorgestrel—Headache—Prednisolone—ankylosing spondylitis	8.53e-05	0.00114	CcSEcCtD
Levonorgestrel—Discomfort—Methotrexate—ankylosing spondylitis	8.52e-05	0.00114	CcSEcCtD
Levonorgestrel—Constipation—Prednisone—ankylosing spondylitis	8.46e-05	0.00113	CcSEcCtD
Levonorgestrel—Dizziness—Triamcinolone—ankylosing spondylitis	8.28e-05	0.0011	CcSEcCtD
Levonorgestrel—Dizziness—Methylprednisolone—ankylosing spondylitis	8.26e-05	0.0011	CcSEcCtD
Levonorgestrel—Infection—Methotrexate—ankylosing spondylitis	8.21e-05	0.00109	CcSEcCtD
Levonorgestrel—Asthenia—Betamethasone—ankylosing spondylitis	8.15e-05	0.00109	CcSEcCtD
Levonorgestrel—Asthenia—Dexamethasone—ankylosing spondylitis	8.15e-05	0.00109	CcSEcCtD
Levonorgestrel—Nervous system disorder—Methotrexate—ankylosing spondylitis	8.11e-05	0.00108	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Prednisone—ankylosing spondylitis	8.09e-05	0.00108	CcSEcCtD
Levonorgestrel—Nausea—Prednisolone—ankylosing spondylitis	8.09e-05	0.00108	CcSEcCtD
Levonorgestrel—Pruritus—Betamethasone—ankylosing spondylitis	8.04e-05	0.00107	CcSEcCtD
Levonorgestrel—Pruritus—Dexamethasone—ankylosing spondylitis	8.04e-05	0.00107	CcSEcCtD
Levonorgestrel—Skin disorder—Methotrexate—ankylosing spondylitis	8.03e-05	0.00107	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Methotrexate—ankylosing spondylitis	7.99e-05	0.00106	CcSEcCtD
Levonorgestrel—Vomiting—Triamcinolone—ankylosing spondylitis	7.96e-05	0.00106	CcSEcCtD
Levonorgestrel—Vomiting—Methylprednisolone—ankylosing spondylitis	7.94e-05	0.00106	CcSEcCtD
Levonorgestrel—Rash—Triamcinolone—ankylosing spondylitis	7.89e-05	0.00105	CcSEcCtD
Levonorgestrel—Dermatitis—Triamcinolone—ankylosing spondylitis	7.89e-05	0.00105	CcSEcCtD
Levonorgestrel—Anorexia—Methotrexate—ankylosing spondylitis	7.88e-05	0.00105	CcSEcCtD
Levonorgestrel—Rash—Methylprednisolone—ankylosing spondylitis	7.88e-05	0.00105	CcSEcCtD
Levonorgestrel—Dermatitis—Methylprednisolone—ankylosing spondylitis	7.87e-05	0.00105	CcSEcCtD
Levonorgestrel—Urticaria—Prednisone—ankylosing spondylitis	7.86e-05	0.00105	CcSEcCtD
Levonorgestrel—Headache—Triamcinolone—ankylosing spondylitis	7.84e-05	0.00104	CcSEcCtD
Levonorgestrel—Headache—Methylprednisolone—ankylosing spondylitis	7.83e-05	0.00104	CcSEcCtD
Levonorgestrel—Abdominal pain—Prednisone—ankylosing spondylitis	7.82e-05	0.00104	CcSEcCtD
Levonorgestrel—Body temperature increased—Prednisone—ankylosing spondylitis	7.82e-05	0.00104	CcSEcCtD
Levonorgestrel—Diarrhoea—Dexamethasone—ankylosing spondylitis	7.77e-05	0.00104	CcSEcCtD
Levonorgestrel—Diarrhoea—Betamethasone—ankylosing spondylitis	7.77e-05	0.00104	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	7.53e-05	0.001	CcSEcCtD
Levonorgestrel—Dizziness—Betamethasone—ankylosing spondylitis	7.51e-05	0.001	CcSEcCtD
Levonorgestrel—Dizziness—Dexamethasone—ankylosing spondylitis	7.51e-05	0.001	CcSEcCtD
Levonorgestrel—Insomnia—Methotrexate—ankylosing spondylitis	7.48e-05	0.000996	CcSEcCtD
Levonorgestrel—Nausea—Triamcinolone—ankylosing spondylitis	7.44e-05	0.000991	CcSEcCtD
Levonorgestrel—Nausea—Methylprednisolone—ankylosing spondylitis	7.42e-05	0.000988	CcSEcCtD
Levonorgestrel—Dyspnoea—Methotrexate—ankylosing spondylitis	7.37e-05	0.000982	CcSEcCtD
Levonorgestrel—Somnolence—Methotrexate—ankylosing spondylitis	7.35e-05	0.000979	CcSEcCtD
Levonorgestrel—Hypersensitivity—Prednisone—ankylosing spondylitis	7.29e-05	0.000971	CcSEcCtD
Levonorgestrel—Dyspepsia—Methotrexate—ankylosing spondylitis	7.28e-05	0.00097	CcSEcCtD
Levonorgestrel—Vomiting—Betamethasone—ankylosing spondylitis	7.22e-05	0.000962	CcSEcCtD
Levonorgestrel—Vomiting—Dexamethasone—ankylosing spondylitis	7.22e-05	0.000962	CcSEcCtD
Levonorgestrel—Decreased appetite—Methotrexate—ankylosing spondylitis	7.19e-05	0.000957	CcSEcCtD
Levonorgestrel—Rash—Dexamethasone—ankylosing spondylitis	7.16e-05	0.000954	CcSEcCtD
Levonorgestrel—Rash—Betamethasone—ankylosing spondylitis	7.16e-05	0.000954	CcSEcCtD
Levonorgestrel—Dermatitis—Dexamethasone—ankylosing spondylitis	7.16e-05	0.000953	CcSEcCtD
Levonorgestrel—Dermatitis—Betamethasone—ankylosing spondylitis	7.16e-05	0.000953	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	7.14e-05	0.000951	CcSEcCtD
Levonorgestrel—Fatigue—Methotrexate—ankylosing spondylitis	7.13e-05	0.00095	CcSEcCtD
Levonorgestrel—Headache—Dexamethasone—ankylosing spondylitis	7.12e-05	0.000948	CcSEcCtD
Levonorgestrel—Headache—Betamethasone—ankylosing spondylitis	7.12e-05	0.000948	CcSEcCtD
Levonorgestrel—Asthenia—Prednisone—ankylosing spondylitis	7.1e-05	0.000946	CcSEcCtD
Levonorgestrel—Pain—Methotrexate—ankylosing spondylitis	7.07e-05	0.000942	CcSEcCtD
Levonorgestrel—Pruritus—Prednisone—ankylosing spondylitis	7e-05	0.000932	CcSEcCtD
Levonorgestrel—Diarrhoea—Prednisone—ankylosing spondylitis	6.77e-05	0.000902	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	6.76e-05	0.000901	CcSEcCtD
Levonorgestrel—Nausea—Betamethasone—ankylosing spondylitis	6.75e-05	0.000899	CcSEcCtD
Levonorgestrel—Nausea—Dexamethasone—ankylosing spondylitis	6.75e-05	0.000899	CcSEcCtD
Levonorgestrel—Urticaria—Methotrexate—ankylosing spondylitis	6.57e-05	0.000875	CcSEcCtD
Levonorgestrel—Dizziness—Prednisone—ankylosing spondylitis	6.54e-05	0.000872	CcSEcCtD
Levonorgestrel—Abdominal pain—Methotrexate—ankylosing spondylitis	6.54e-05	0.000871	CcSEcCtD
Levonorgestrel—Body temperature increased—Methotrexate—ankylosing spondylitis	6.54e-05	0.000871	CcSEcCtD
Levonorgestrel—Vomiting—Prednisone—ankylosing spondylitis	6.29e-05	0.000838	CcSEcCtD
Levonorgestrel—Rash—Prednisone—ankylosing spondylitis	6.24e-05	0.000831	CcSEcCtD
Levonorgestrel—Dermatitis—Prednisone—ankylosing spondylitis	6.23e-05	0.00083	CcSEcCtD
Levonorgestrel—Headache—Prednisone—ankylosing spondylitis	6.2e-05	0.000826	CcSEcCtD
Levonorgestrel—Hypersensitivity—Methotrexate—ankylosing spondylitis	6.09e-05	0.000811	CcSEcCtD
Levonorgestrel—Asthenia—Methotrexate—ankylosing spondylitis	5.93e-05	0.00079	CcSEcCtD
Levonorgestrel—Nausea—Prednisone—ankylosing spondylitis	5.88e-05	0.000783	CcSEcCtD
Levonorgestrel—Pruritus—Methotrexate—ankylosing spondylitis	5.85e-05	0.000779	CcSEcCtD
Levonorgestrel—Diarrhoea—Methotrexate—ankylosing spondylitis	5.66e-05	0.000754	CcSEcCtD
Levonorgestrel—Dizziness—Methotrexate—ankylosing spondylitis	5.47e-05	0.000728	CcSEcCtD
Levonorgestrel—Vomiting—Methotrexate—ankylosing spondylitis	5.26e-05	0.0007	CcSEcCtD
Levonorgestrel—Rash—Methotrexate—ankylosing spondylitis	5.21e-05	0.000694	CcSEcCtD
Levonorgestrel—Dermatitis—Methotrexate—ankylosing spondylitis	5.21e-05	0.000694	CcSEcCtD
Levonorgestrel—Headache—Methotrexate—ankylosing spondylitis	5.18e-05	0.00069	CcSEcCtD
Levonorgestrel—Nausea—Methotrexate—ankylosing spondylitis	4.91e-05	0.000654	CcSEcCtD
